Currently out of the existing stock ratings of Chris Howerton, 124 are a BUY (79.49%), 27 are a HOLD (17.31%), 5 are a SELL (3.21%).

Chris Howerton

Work Performance Price Targets & Ratings Chart

Analyst Chris Howerton, carries an average stock price target met ratio of 56.17% that have a potential upside of 39.49% achieved within 256 days. Previously, Chris Howerton worked at JEFFERIES.

Chris Howerton’s has documented 308 price targets and ratings displayed on 53 stocks. The coverage was on Healthcare, Consumer Cyclical, Technology sectors.

Most recent stock forecast was given on URGN, UroGen Pharma Ltd at 10-Apr-2026.

Wall Street Analyst Chris Howerton

Analyst best performing recommendations are on AVD (AMERICAN VANGUARD).
The best stock recommendation documented was for NERV (MINERVA NEUROSCIENCES) at 5/12/2016. The price target of $80 was fulfilled within 14 days with a profit of $35.44 (79.53%) receiving and performance score of 56.81.

Average potential price target upside

of $356.64 (63.49%) on BTAI (BIOXCEL THERAPEUTICS).
of $57.25 (50.6%) on KRTX (KARUNA THERAPEUTICS).
of $48.14 (87.21%) on AXSM (AXSOME THERAPEUTICS).

ACAD ACADIA Pharmaceuticals AMTI Applied Molecular Transport AXSM Axsome Therapeutics BTAI BioXcel Therapeutics GMTX Gemini Therapeutics IMMU Immunomedics KRTX Karuna Therapeutics MCRB Seres Therapeutics PSTI Pluristem TGTX TG Therapeutics TXMD TherapeuticsMD VERU Veru VNDA Vanda Pharmaceuticals CARA Cara Therapeutic SPPI Spectrum Pharmaceuticals APLS Apellis Pharmaceuticals ARDX Ardelyx ARNA Arena Pharmaceuticals AVDL Avadel Pharmaceuticals PLC CLDX Celldex Therapeutics EVLO Evelo Biosciences HRMY Harmony Biosciences Holdings IGMS IGM Biosciences MEIP MEI Pharma AVTX Avalo Therapeutics FNCH Finch Therapeutics Group ISEE IVERIC bio LABP Landos Biopharma PNT POINT Biopharma Global TCRT Alaunos Therapeutics ZIOP ZIOPHARM Oncology PRVB Provention Bio KDMN Kadmon Holdings CGEN Compugen CORT Corcept Therapeutics IOBT IO Biotech LQDA Liquidia Technologies MIST Milestone Pharmaceuticals PTGX Protagonist Therapeutics URGN UroGen Pharma Ltd VRDN Viridian Therapeutics GPCR Structure Therapeutics American Depositary Shares NERV Minerva Neurosciences SESN Sesen Bio ALNA Allena Pharmaceuticals AMT American Tower Corp AVD American Vanguard CADL Candel Therapeutics CERC Cerecor GM General Motors Company MEI Methode Electronics SBBP Strongbridge Biopharma plc TCRX Tscan Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Brian Abrahams (RBC)